Prevalence, Prevention and Management of Bronchopulmonary Dysplasia

References

• Northway WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967;276(7):357–368. doi:10.1056/NEJM196702162760701
   PubMed Web of Science ®Google Scholar
• Allen J, Panitch H. Bronchopulmonary dysplasia-A historical perspective. Pediatr Pulmonol. 2021;56(11):3478–3489. doi:10.1002/ppul.25341
   PubMed Web of Science ®Google Scholar
• Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res. 1999;46(6):641–643. doi:10.1203/00006450-199912000-00007
   PubMed Web of Science ®Google Scholar
• Bell EF, Hintz SR, Hansen NI, et al. Mortality, in-hospital morbidity, care practices, and 2-year outcomes for extremely preterm infants in the US, 2013–2018. JAMA. 2022;327(3):248–263. doi:10.1001/jama.2021.23580
   PubMed Web of Science ®Google Scholar
• Nakashima T, Inoue H, Sakemi Y, et al. Trends in bronchopulmonary dysplasia among extremely preterm infants in Japan, 2003–2016. J Pediatr. 2021;230:119–125.e7. doi:10.1016/j.jpeds.2020.11.041
   PubMed Web of Science ®Google Scholar
• Gilfillan M, Bhandari V. Moving bronchopulmonary dysplasia research from the bedside to the bench. Am J Physiol Lung Cell Mol Physiol. 2022;322(6):L804–L821. doi:10.1152/ajplung.00452.2021
   PubMed Web of Science ®Google Scholar
• Mandell EW, Kratimenos P, Abman SH, Steinhorn RH. Drugs for the prevention and treatment of bronchopulmonary dysplasia. Clin Perinatol. 2019;46(2):291–310. doi:10.1016/j.clp.2019.02.011
   PubMed Web of Science ®Google Scholar
• Lui K, Lee SK, Kusuda S, et al. Trends in outcomes for neonates born very preterm and very low birth weight in 11 high-income countries. J Pediatr. 2019;215:32–40.e14. doi:10.1016/j.jpeds.2019.08.020
   PubMed Web of Science ®Google Scholar
• van Katwyk S, Augustine S, Thebaud B, Thavorn K. Lifetime patient outcomes and healthcare utilization for Bronchopulmonary dysplasia (BPD) and extreme preterm infants: a microsimulation study. BMC Pediatr. 2020;20(1):136. doi:10.1186/s12887-020-02037-5
   PubMed Web of Science ®Google Scholar
• Cheong JLY, Doyle LW. An update on pulmonary and neurodevelopmental outcomes of bronchopulmonary dysplasia. Semin Perinatol. 2018;42(7):478–484. doi:10.1053/j.semperi.2018.09.013
   PubMed Web of Science ®Google Scholar
• Shin JE, Jang H, Han JH, et al. Association between bronchopulmonary dysplasia and early respiratory morbidity in children with respiratory distress syndrome: a case-control study using nationwide data. Sci Rep. 2022;12(1):7578. doi:10.1038/s41598-022-11657-z
   PubMed Web of Science ®Google Scholar
• Humayun J, Lofqvist C, Ley D, Hellstrom A, Gyllensten H. Systematic review of the healthcare cost of bronchopulmonary dysplasia. BMJ Open. 2021;11(8):e045729. doi:10.1136/bmjopen-2020-045729
   PubMed Web of Science ®Google Scholar
• Thunqvist P, Tufvesson E, Bjermer L, et al. Lung function after extremely preterm birth-A population-based cohort study (EXPRESS). Pediatr Pulmonol. 2018;53(1):64–72. doi:10.1002/ppul.23919
   PubMed Web of Science ®Google Scholar
• Keller RL, Feng R, DeMauro SB, et al. Bronchopulmonary dysplasia and perinatal characteristics predict 1-year respiratory outcomes in newborns born at extremely low gestational age: a prospective cohort study. J Pediatr. 2017;187:89–97.e3. doi:10.1016/j.jpeds.2017.04.026
   PubMed Web of Science ®Google Scholar
• Mowitz ME, Mangili A, Han L, et al. Prevalence of chronic respiratory morbidity, length of stay, inpatient readmissions, and costs among extremely preterm infants with bronchopulmonary dysplasia. Expert Rev Pharmacoecon Outcomes Res. 2021;21(5):1117–1125. doi:10.1080/14737167.2021.1848554
   PubMed Web of Science ®Google Scholar
• Nobile S, Marchionni P, Gidiucci C, et al. Oxygen saturation/FIO2 ratio at 36 weeks’ PMA in 1005 preterm infants: effect of gestational age and early respiratory disease patterns. Pediatr Pulmonol. 2019;54(5):637–643. doi:10.1002/ppul.24265
   PubMed Web of Science ®Google Scholar
• Chan JY, Stern DA, Guerra S, Wright AL, Morgan WJ, Martinez FD. Pneumonia in childhood and impaired lung function in adults: a longitudinal study. Pediatrics. 2015;135(4):607–616. doi:10.1542/peds.2014-3060
   PubMed Web of Science ®Google Scholar
• Morrow LA, Wagner BD, Ingram DA, et al. Antenatal determinants of bronchopulmonary dysplasia and late respiratory disease in preterm infants. Am J Respir Crit Care Med. 2017;196(3):364–374. doi:10.1164/rccm.201612-2414OC
   PubMed Web of Science ®Google Scholar
• Bührer C, Heller G, Thome UH. Population-based outcome data of extremely preterm infants in Germany during 2010–2017. Neonatology. 2022;119(3):370–376. doi:10.1159/000524455
   PubMed Web of Science ®Google Scholar
• Lundgren P, Morsing E, Hård AL, et al. National cohort of infants born before 24 gestational weeks showed increased survival rates but no improvement in neonatal morbidity. Acta Paediatr. 2022;111(8):1515–1525. doi:10.1111/apa.16354
   PubMed Web of Science ®Google Scholar
• Shukla VV, Souder JP, Imbrock G, et al. Hospital and neurodevelopmental outcomes in nano-preterm infants receiving invasive vs noninvasive ventilation at birth. JAMA Netw Open. 2022;5(8):e2229105. doi:10.1001/jamanetworkopen.2022.29105
   PubMed Web of Science ®Google Scholar
• Chung J, Iyengar A, Santry L, Swanson E, Davis JM, Volpe MV. Changes in respiratory management and the impact on bronchopulmonary dysplasia. Pediatr Pulmonol. 2022;57(10):2327–2334. doi:10.1002/ppul.26035
   PubMed Web of Science ®Google Scholar
• Yao S, Uthaya S, Gale C, Modi N, Battersby C; (UKNC) UNC. Postnatal corticosteroid use for prevention or treatment of bronchopulmonary dysplasia in England and Wales 2012–2019: a retrospective population cohort study. BMJ Open. 2022;12(11):e063835. doi:10.1136/bmjopen-2022-063835
   PubMed Web of Science ®Google Scholar
• Lee SM, Sie L, Liu J, Profit J, Lee HC. Evaluation of trends in bronchopulmonary dysplasia and respiratory support practice for very low birth weight infants: a population-based cohort study. J Pediatr. 2022;243:47–52.e2. doi:10.1016/j.jpeds.2021.11.049
   PubMed Web of Science ®Google Scholar
• Regin Y, Gie A, Eerdekens A, Toelen J, Debeer A. Ventilation and respiratory outcome in extremely preterm infants: trends in the new millennium. Eur J Pediatr. 2022;181(5):1899–1907. doi:10.1007/s00431-022-04378-y
   PubMed Web of Science ®Google Scholar
• Jensen EA, Edwards EM, Greenberg LT, Soll RF, Ehret DEY, Horbar JD. Severity of bronchopulmonary dysplasia among very preterm infants in the United States. Pediatrics. 2021;148(1). doi:10.1542/peds.2020-030007
   PubMed Web of Science ®Google Scholar
• Sucasas Alonso A, Pértega Diaz S, Sáez Soto R, Avila-Alvarez A. Epidemiology and risk factors for bronchopulmonary dysplasia in preterm infants born at or less than 32 weeks of gestation. An Pediatr. 2022;96(3):242–251. doi:10.1016/j.anpede.2021.03.006
   Google Scholar
• Geetha O, Rajadurai VS, Anand AJ, et al. New BPD-prevalence and risk factors for bronchopulmonary dysplasia/mortality in extremely low gestational age infants ≤28 weeks. J Perinatol. 2021;41(8):1943–1950. doi:10.1038/s41372-021-01095-6
   PubMed Web of Science ®Google Scholar
• Ramos-Navarro C, Maderuelo-Rodríguez E, Concheiro-Guisán A, et al. Risk factors and bronchopulmonary dysplasia severity: data from the Spanish Bronchopulmonary Dysplasia Research Network. Eur J Pediatr. 2022;181(2):789–799. doi:10.1007/s00431-021-04248-z
   PubMed Web of Science ®Google Scholar
• He W, Zhang L, Feng R, et al. Risk factors and machine learning prediction models for bronchopulmonary dysplasia severity in the Chinese population. World J Pediatr. 2023;19(6):568–576. doi:10.1007/s12519-022-00635-0
   PubMed Web of Science ®Google Scholar
• Dou C, Yu Y-H, Zhuo Q-C, et al. Longer duration of initial invasive mechanical ventilation is still a crucial risk factor for moderate-to-severe bronchopulmonary dysplasia in very preterm infants: a multicentrer prospective study. World J Pediatr. 2023;19(6):577–585. doi:10.1007/s12519-022-00671-w
   PubMed Web of Science ®Google Scholar
• Greenberg RG, McDonald SA, Laughon MM, et al. Online clinical tool to estimate risk of bronchopulmonary dysplasia in extremely preterm infants. Arch Dis Child Fetal Neonatal Ed. 2022;107(6):638–643. doi:10.1136/archdischild-2021-323573
   Web of Science ®Google Scholar
• Gilfillan M, Bhandari A, Bhandari V. Diagnosis and management of bronchopulmonary dysplasia. BMJ. 2021;375:n1974. doi:10.1136/bmj.n1974
   PubMedGoogle Scholar
• Gobec K, Mukenauer R, Keše D, Erčulj V, Grosek Š, Perme T. Association between colonization of the respiratory tract with Ureaplasma species and bronchopulmonary dysplasia in newborns with extremely low gestational age: a retrospective study. Croat Med J. 2023;64(2):75–83. doi:10.3325/cmj.2023.64.75
   PubMed Web of Science ®Google Scholar
• Pierro M, Villamor-Martinez E, van Westering-Kroon E, Alvarez-Fuente M, Abman SH, Villamor E. Association of the dysfunctional placentation endotype of prematurity with bronchopulmonary dysplasia: a systematic review, meta-analysis and meta-regression. Thorax. 2022;77(3):268–275. doi:10.1136/thoraxjnl-2020-216485
   PubMed Web of Science ®Google Scholar
• Sheth S, Goto L, Bhandari V, Abraham B, Mowes A. Factors associated with development of early and late pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. J Perinatol. 2020;40(1):138–148. doi:10.1038/s41372-019-0549-9
   PubMed Web of Science ®Google Scholar
• Jensen EA, Dysart K, Gantz MG, et al. The diagnosis of bronchopulmonary dysplasia in very preterm infants. An evidence-based approach. Am J Respir Crit Care Med. 2019;200(6):751–759. doi:10.1164/rccm.201812-2348OC
   PubMed Web of Science ®Google Scholar
• Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163(7):1723–1729. doi:10.1164/ajrccm.163.7.2011060
   PubMedGoogle Scholar
• Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics. 1988;82(4):527–532. doi:10.1542/peds.82.4.527
   PubMed Web of Science ®Google Scholar
• Walsh MC, Yao Q, Gettner P, et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics. 2004;114(5):1305–1311. doi:10.1542/peds.2004-0204
   PubMed Web of Science ®Google Scholar
• Isayama T, Lee SK, Yang J, et al. Revisiting the definition of bronchopulmonary dysplasia: effect of changing panoply of respiratory support for preterm neonates. JAMA Pediatr. 2017;171(3):271–279. doi:10.1001/jamapediatrics.2016.4141
   PubMed Web of Science ®Google Scholar
• Adler-Haltovsky T, Gileles-Hillel A, Erlichman I, Eventov-Friedman S. Changes in ventilation modes in the last decade and their impact on the prevalence of bronchopulmonary dysplasia in preterm infants. Pediatr Pulmonol. 2023;58(7):1959–1966. doi:10.1002/ppul.26418
   PubMed Web of Science ®Google Scholar
• Higgins RD, Jobe AH, Koso-Thomas M, et al. Bronchopulmonary dysplasia: executive summary of a workshop. J Pediatr. 2018;197:300–308. doi:10.1016/j.jpeds.2018.01.043
   PubMed Web of Science ®Google Scholar
• Kim F, Bateman DA, Goldshtrom N, Sahni R, Wung JT, Wallman-Stokes A. Revisiting the definition of bronchopulmonary dysplasia in premature infants at a single center quaternary neonatal intensive care unit. J Perinatol. 2021;41(4):756–763. doi:10.1038/s41372-021-00980-4
   PubMed Web of Science ®Google Scholar
• Kurihara C, Zhang L, Mikhael M. Newer bronchopulmonary dysplasia definitions and prediction of health economics impacts in very preterm infants. Pediatr Pulmonol. 2021;56(2):409–417. doi:10.1002/ppul.25172
   PubMed Web of Science ®Google Scholar
• Guaman MC, Pishevar N, Abman SH, et al. Invasive mechanical ventilation at 36 weeks post-menstrual age, adverse outcomes with a comparison of recent definitions of bronchopulmonary dysplasia. J Perinatol. 2021;41(8):1936–1942. doi:10.1038/s41372-021-01102-w
   PubMed Web of Science ®Google Scholar
• Oluwole I, Tan JBC, DeSouza S, et al. The association between bronchopulmonary dysplasia grade and risks of adverse neurodevelopmental outcomes among preterm infants born at less than 30 weeks of gestation. J Matern Fetal Neonatal Med. 2023;36(1):2167074. doi:10.1080/14767058.2023.2167074
   PubMed Web of Science ®Google Scholar
• Jeon GW, Oh M, Chang YS. Definitions of bronchopulmonary dysplasia and long-term outcomes of extremely preterm infants in Korean Neonatal Network. Sci Rep. 2021;11(1):24349. doi:10.1038/s41598-021-03644-7
   PubMed Web of Science ®Google Scholar
• Jeon GW, Oh M, Lee J, Jun YH, Chang YS. Comparison of definitions of bronchopulmonary dysplasia to reflect the long-term outcomes of extremely preterm infants. Sci Rep. 2022;12(1):18095. doi:10.1038/s41598-022-22920-8
   PubMed Web of Science ®Google Scholar
• Katz TA, van Kaam AH, Schuit E, et al. Comparison of new bronchopulmonary dysplasia definitions on long-term outcomes in preterm infants. J Pediatr. 2022. doi:10.1016/j.jpeds.2022.09.022
   Web of Science ®Google Scholar
• Isayama T, Iwami H, McDonald S, Beyene J. Association of noninvasive ventilation strategies with mortality and bronchopulmonary dysplasia among preterm infants: a systematic review and meta-analysis. JAMA. 2016;316(6):611–624. doi:10.1001/jama.2016.10708
   PubMed Web of Science ®Google Scholar
• Collaco JM, McGrath-Morrow SA. Bronchopulmonary dysplasia as a determinant of respiratory outcomes in adult life. Pediatr Pulmonol. 2021;56(11):3464–3471. doi:10.1002/ppul.25301
   PubMed Web of Science ®Google Scholar
• Collaco JM, Tracy MC, Sheils CA, et al. Insurance coverage and respiratory morbidities in bronchopulmonary dysplasia. Pediatr Pulmonol. 2022;57(7):1735–1743. doi:10.1002/ppul.25933
   PubMed Web of Science ®Google Scholar
• Banwell E, Collaco JM, Oates GR, et al. Area deprivation and respiratory morbidities in children with bronchopulmonary dysplasia. Pediatr Pulmonol. 2022;57(9):2053–2059. doi:10.1002/ppul.25969
   PubMed Web of Science ®Google Scholar
• Deschamps J, Boucekine M, Fayol L, et al. Neighborhood disadvantage and early respiratory outcomes in very preterm infants with bronchopulmonary dysplasia. J Pediatr. 2021;237:177–182.e1. doi:10.1016/j.jpeds.2021.06.061
   PubMed Web of Science ®Google Scholar
• Smith MA, Steurer MA, Mahendra M, Zinter MS, Keller RL. Sociodemographic factors associated with tracheostomy and mortality in bronchopulmonary dysplasia. Pediatr Pulmonol. 2023;58(4):1237–1246. doi:10.1002/ppul.26328
   PubMed Web of Science ®Google Scholar
• Pierro M, Van Mechelen K, van Westering-Kroon E, Villamor-Martínez E, Villamor E. Endotypes of prematurity and phenotypes of bronchopulmonary dysplasia: toward personalized neonatology. J Pers Med. 2022;12(5):687. doi:10.3390/jpm12050687
   PubMed Web of Science ®Google Scholar
• Wu KY, Jensen EA, White AM, et al. Characterization of disease phenotype in very preterm infants with severe bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2020;201(11):1398–1406. doi:10.1164/rccm.201907-1342OC
   PubMed Web of Science ®Google Scholar
• Hysinger EB, Friedman NL, Padula MA, et al. Tracheobronchomalacia is associated with increased morbidity in bronchopulmonary dysplasia. Ann Am Thorac Soc. 2017;14(9):1428–1435. doi:10.1513/AnnalsATS.201702-178OC
   PubMed Web of Science ®Google Scholar
• Collaco JM, McGrath-Morrow SA. Respiratory phenotypes for preterm infants, children, and adults: bronchopulmonary dysplasia and more. Ann Am Thorac Soc. 2018;15(5):530–538. doi:10.1513/AnnalsATS.201709-756FR
   PubMed Web of Science ®Google Scholar
• Gilfillan M, Bhandari V. Pulmonary phenotypes of bronchopulmonary dysplasia in the preterm infant. Semin Perinatol. 2023;47(6):151810. doi:10.1016/j.semperi.2023.151810
   PubMed Web of Science ®Google Scholar
• Bhat R, Salas AA, Foster C, Carlo WA, Ambalavanan N. Prospective analysis of pulmonary hypertension in extremely low birth weight infants. Pediatrics. 2012;129(3):e682–9. doi:10.1542/peds.2011-1827
   PubMed Web of Science ®Google Scholar
• Hysinger EB. Central airway issues in bronchopulmonary dysplasia. Pediatr Pulmonol. 2021;56(11):3518–3526. doi:10.1002/ppul.25417
   PubMed Web of Science ®Google Scholar
• Praprotnik M, Stucin Gantar I, Krivec U, Lucovnik M, Rodman Berlot J, Starc G. Physical fitness trajectories from childhood to adolescence in extremely preterm children: a longitudinal cohort study. Pediatr Pulmonol. 2023;58(7):1904–1911. doi:10.1002/ppul.26410
   PubMed Web of Science ®Google Scholar
• Peralta GP, Piatti R, Haile SR, et al. Respiratory morbidity in preschool and school-age children born very preterm and its association with parents’ health-related quality of life and family functioning. Eur J Pediatr. 2023;182(3):1201–1210. doi:10.1007/s00431-022-04783-3
   PubMed Web of Science ®Google Scholar
• Sriram S, Schreiber MD, Msall ME, et al. Cognitive development and quality of life associated with BPD in 10-year-olds born preterm. Pediatrics. 2018;141(6). doi:10.1542/peds.2017-2719
   PubMed Web of Science ®Google Scholar
• Doyle LW, Irving L, Haikerwal A, Lee K, Ranganathan S, Cheong J. Airway obstruction in young adults born extremely preterm or extremely low birth weight in the postsurfactant era. Thorax. 2019;74(12):1147–1153. doi:10.1136/thoraxjnl-2019-213757
   PubMed Web of Science ®Google Scholar
• Doyle LW, Ranganathan S, Cheong J; Group VICS. Bronchopulmonary dysplasia and expiratory airflow at 8 years in children born extremely preterm in the post-surfactant era. Thorax. 2023;78(5):484–488. doi:10.1136/thoraxjnl-2022-218792
   PubMed Web of Science ®Google Scholar
• Harris C, Morris S, Lunt A, Peacock J, Greenough A. Influence of bronchopulmonary dysplasia on lung function in adolescents who were born extremely prematurely. Pediatr Pulmonol. 2022;57(12):3151–3157. doi:10.1002/ppul.26151
   PubMed Web of Science ®Google Scholar
• Tan S, Szatkowski L, Moreton W, et al. Early childhood respiratory morbidity and antibiotic use in ex-preterm infants: a primary care population-based cohort study. Eur Respir J. 2020;56(1):2000202. doi:10.1183/13993003.00202-2020
   PubMed Web of Science ®Google Scholar
• Kim K, Lee JY, Kim YM, et al. Prevalence of asthma in preterm and associated risk factors based on prescription data from the Korean National Health Insurance database. Sci Rep. 2023;13(1):4484. doi:10.1038/s41598-023-31558-z
   PubMed Web of Science ®Google Scholar
• Siffel C, Hirst AK, Sarda SP, et al. The clinical burden of extremely preterm birth in a large medical records database in the United States: complications, medication use, and healthcare resource utilization. J Matern Fetal Neonatal Med. 2022;35(26):10271–10278. doi:10.1080/14767058.2022.2122035
   PubMed Web of Science ®Google Scholar
• Doyle LW, Andersson S, Bush A, et al. Expiratory airflow in late adolescence and early adulthood in individuals born very preterm or with very low birthweight compared with controls born at term or with normal birthweight: a meta-analysis of individual participant data. Lancet Respir Med. 2019;7(8):677–686. doi:10.1016/S2213-2600(18)30530-7
   PubMed Web of Science ®Google Scholar
• Bårdsen T, Røksund OD, Benestad MR, et al. Tracking of lung function from 10 to 35 years after being born extremely preterm or with extremely low birth weight. Thorax. 2022;77(8):790–798. doi:10.1136/thoraxjnl-2021-218400
   PubMed Web of Science ®Google Scholar
• Prenzel F, Vogel M, Siekmeyer W, Körner A, Kiess W, Vom Hove M. Exercise capacity in children with bronchopulmonary dysplasia at school age. Respir Med. 2020;171:106102. doi:10.1016/j.rmed.2020.106102
   PubMed Web of Science ®Google Scholar
• McGrath-Morrow SA, Collaco JM. Bronchopulmonary dysplasia: what are its links to COPD? Ther Adv Respir Dis. 2019;13:1753466619892492. doi:10.1177/1753466619892492
   Web of Science ®Google Scholar
• DeMauro SB. Neurodevelopmental outcomes of infants with bronchopulmonary dysplasia. Pediatr Pulmonol. 2021;56(11):3509–3517. doi:10.1002/ppul.25381
   PubMed Web of Science ®Google Scholar
• Martin M, Smith L, Hofheimer JA, et al. Bronchopulmonary dysplasia and neurobehavioural outcomes at birth and 2 years in infants born before 30 weeks. Arch Dis Child Fetal Neonatal Ed. 2023;108(2):142–148. doi:10.1136/archdischild-2021-323405
   PubMed Web of Science ®Google Scholar
• Tréluyer L, Nuytten A, Guellec I, et al. Neurodevelopment and healthcare utilisation at age 5–6 years in bronchopulmonary dysplasia: an EPIPAGE-2 cohort study. Arch Dis Child Fetal Neonatal Ed. 2023:325376. doi:10.1136/archdischild-2023-325376
   Web of Science ®Google Scholar
• Carregã M, Sousa P, Rocha G, Ferreira-Magalhães M, Azevedo I. Respiratory and non-respiratory outcomes of bronchopulmonary dysplasia in adolescents: a systematic review. Early Hum Dev. 2023;180:105756. doi:10.1016/j.earlhumdev.2023.105756
   PubMed Web of Science ®Google Scholar
• Lapcharoensap W, Bennett MV, Xu X, Lee HC, Dukhovny D. Hospitalization costs associated with bronchopulmonary dysplasia in the first year of life. J Perinatol. 2020;40(1):130–137. doi:10.1038/s41372-019-0548-x
   PubMed Web of Science ®Google Scholar
• Lai KC, Lorch SA. Healthcare costs of major morbidities associated with prematurity in US children’s hospitals. J Pediatr. 2023;256:53–62.e4. doi:10.1016/j.jpeds.2022.11.038
   PubMed Web of Science ®Google Scholar
• Villosis MFB, Barseghyan K, Ambat MT, Rezaie KK, Braun D. Rates of bronchopulmonary dysplasia following implementation of a novel prevention bundle. JAMA Netw Open. 2021;4(6):e2114140. doi:10.1001/jamanetworkopen.2021.14140
   PubMed Web of Science ®Google Scholar
• Ratliff-Crain D, Wallingford B, Jorgenson L. Using a bundle approach to prevent bronchopulmonary dysplasia in very premature infants. Adv Neonatal Care. 2022;22(4):300–308. doi:10.1097/ANC.0000000000000920
   PubMed Web of Science ®Google Scholar
• White H, Merritt K, Martin K, Lauer E, Rhein L. Respiratory support strategies in the prevention of bronchopulmonary dysplasia: a single center quality improvement initiative. Front Pediatr. 2022;10:1012655. doi:10.3389/fped.2022.1012655
   PubMed Web of Science ®Google Scholar
• Oei JL, Vento M, Rabi Y, et al. Higher or lower oxygen for delivery room resuscitation of preterm infants below 28 completed weeks gestation: a meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2017;102(1):F24–F30. doi:10.1136/archdischild-2016-310435
   PubMed Web of Science ®Google Scholar
• Askie LM, Darlow BA, Davis PG, et al. Effects of targeting lower versus higher arterial oxygen saturations on death or disability in preterm infants. Cochrane Database Syst Rev. 2017;4:CD011190. doi:10.1002/14651858.CD011190.pub2
   PubMed Web of Science ®Google Scholar
• Bahadue FL, Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2012;11(11):CD001456. doi:10.1002/14651858.CD001456.pub2
   PubMed Web of Science ®Google Scholar
• Bhandari V, Black R, Gandhi B, et al. RDS-NExT workshop: consensus statements for the use of surfactant in preterm neonates with RDS. J Perinatol. 2023;43(8):982–990. doi:10.1038/s41372-023-01690-9
   PubMed Web of Science ®Google Scholar
• Kakkilaya V, Wagner S, Mangona KLM, et al. Early predictors of continuous positive airway pressure failure in preterm neonates. J Perinatol. 2019;39(8):1081–1088. doi:10.1038/s41372-019-0392-z
   PubMed Web of Science ®Google Scholar
• Gulczyńska E, Szczapa T, Hożejowski R, Borszewska-Kornacka MK, Rutkowska M. Fraction of inspired oxygen as a predictor of CPAP failure in preterm infants with respiratory distress syndrome: a prospective multicenter study. Neonatology. 2019;116(2):171–178. doi:10.1159/000499674
   PubMed Web of Science ®Google Scholar
• Lemyre B, Deguise MO, Benson P, Kirpalani H, Ekhaguere OA, Davis PG. Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infants. Cochrane Database Syst Rev. 2023;7(7):CD005384. doi:10.1002/14651858.CD005384.pub3
   PubMedGoogle Scholar
• Klingenberg C, Wheeler KI, McCallion N, Morley CJ, Davis PG. Volume-targeted versus pressure-limited ventilation in neonates. Cochrane Database Syst Rev. 2017;10(10):CD003666. doi:10.1002/14651858.CD003666.pub4
   PubMedGoogle Scholar
• Cools F, Offringa M, Askie LM. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. Cochrane Database Syst Rev. 2015;3:CD000104. doi:10.1002/14651858.CD000104.pub4
   Google Scholar
• Kamlin C, Davis PG. Long versus short inspiratory times in neonates receiving mechanical ventilation. Cochrane Database Syst Rev. 2004;4:CD004503. doi:10.1002/14651858.CD004503.pub2
   Google Scholar
• Ambalavanan N, Carlo WA. Ventilatory strategies in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol. 2006;30(4):192–199. doi:10.1053/j.semperi.2006.05.006
   PubMed Web of Science ®Google Scholar
• Thome UH, Ambalavanan N. Permissive hypercapnia to decrease lung injury in ventilated preterm neonates. Semin Fetal Neonatal Med. 2009;14(1):21–27. doi:10.1016/j.siny.2008.08.005
   PubMed Web of Science ®Google Scholar
• Thome UH, Genzel-Boroviczeny O, Bohnhorst B, et al. Permissive hypercapnia in extremely low birthweight infants (PHELBI): a randomised controlled multicentre trial. Lancet Respir Med. 2015;3(7):534–543. doi:10.1016/S2213-2600(15)00204-0
   PubMed Web of Science ®Google Scholar
• Bhandari V. Nasal intermittent positive pressure ventilation in the newborn: review of literature and evidence-based guidelines. J Perinatol. 2010;30(8):505–512. doi:10.1038/jp.2009.165
   PubMed Web of Science ®Google Scholar
• Schmidt B, Roberts RS, Davis P, et al. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006;354(20):2112–2121. doi:10.1056/NEJMoa054065
   PubMed Web of Science ®Google Scholar
• Davis PG, Schmidt B, Roberts RS, et al. Caffeine for Apnea of Prematurity trial: benefits may vary in subgroups. J Pediatr. 2010;156(3):382–387. doi:10.1016/j.jpeds.2009.09.069
   PubMed Web of Science ®Google Scholar
• Doyle LW, Schmidt B, Anderson PJ, et al. Reduction in developmental coordination disorder with neonatal caffeine therapy. J Pediatr. 2014;165(2):356–359.e2. doi:10.1016/j.jpeds.2014.04.016
   PubMed Web of Science ®Google Scholar
• Henderson-Smart DJ, Davis PG. Prophylactic methylxanthines for endotracheal extubation in preterm infants. Cochrane Database Syst Rev. 2010;12:CD000139. doi:10.1002/14651858.CD000139.pub2
   Google Scholar
• Yeh TF, Chen CM, Wu SY, et al. Intratracheal administration of budesonide/surfactant to prevent bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2016;193(1):86–95. doi:10.1164/rccm.201505-0861OC
   PubMed Web of Science ®Google Scholar
• Tyson JE, Wright LL, Oh W, et al. Vitamin A supplementation for extremely-low-birth-weight infants. National institute of child health and human development neonatal research network. N Engl J Med. 1999;340(25):1962–1968. doi:10.1056/NEJM199906243402505
   PubMed Web of Science ®Google Scholar
• Ambalavanan N, Tyson JE, Kennedy KA, et al. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics. 2005;115(3):e249–54. doi:10.1542/peds.2004-1812
   PubMed Web of Science ®Google Scholar
• Doyle LW, Cheong JL, Hay S, Manley BJ, Halliday HL. Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev. 2021;10(10):CD001146. doi:10.1002/14651858.CD001146.pub6
   PubMedGoogle Scholar
• Letouzey M, Lorthe E, Marchand-Martin L, et al. Early antibiotic exposure and adverse outcomes in very preterm infants at low risk of early-onset sepsis: the EPIPAGE-2 cohort study. J Pediatr. 2022;243:91–98.e4. doi:10.1016/j.jpeds.2021.11.075
   PubMed Web of Science ®Google Scholar
• Starr MC, Griffin R, Gist KM, et al. Association of fluid balance with short- and long-term respiratory outcomes in extremely premature neonates: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2022;5(12):e2248826. doi:10.1001/jamanetworkopen.2022.48826
   PubMed Web of Science ®Google Scholar
• Uberos J, Jimenez-Montilla S, Molina-Oya M, García-Serrano JL. Early energy restriction in premature infants and bronchopulmonary dysplasia: a cohort study. Br J Nutr. 2020;123(9):1024–1031. doi:10.1017/S0007114520000240
   PubMed Web of Science ®Google Scholar
• Schanler RJ, Lau C, Hurst NM, Smith EO. Randomized trial of donor human milk versus preterm formula as substitutes for mothers’ own milk in the feeding of extremely premature infants. Pediatrics. 2005;116(2):400–406. doi:10.1542/peds.2004-1974
   PubMed Web of Science ®Google Scholar
• Uberos-Fernández J, Ruiz-López A, Carrasco-Solis M, Fernandez-Marín E, Garcia-Cuesta A, Campos-Martínez A. Extrauterine growth restriction and low energy intake during the early neonatal period of very low birth weight infants are associated with decreased lung function in childhood. Br J Nutr. 2023;1–9. doi:10.1017/S0007114523001332
   Web of Science ®Google Scholar
• Doyle LW, Davis PG, Morley CJ, McPhee A, Carlin JB, Investigators DS. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial. Pediatrics. 2006;117(1):75–83. doi:10.1542/peds.2004-2843
   PubMed Web of Science ®Google Scholar
• Doyle LW, Cheong JL, Hay S, Manley BJ, Halliday HL. Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev. 2021;11(11):CD001145. doi:10.1002/14651858.CD001145.pub5
   PubMedGoogle Scholar
• Jensen EA, Wiener LE, Rysavy MA, et al. Assessment of corticosteroid therapy and death or disability according to pretreatment risk of death or bronchopulmonary dysplasia in extremely preterm infants. JAMA Netw Open. 2023;6(5):e2312277. doi:10.1001/jamanetworkopen.2023.12277
   PubMed Web of Science ®Google Scholar
• Dumpa V, Avulakunta I, Bhandari V. Respiratory management in the premature neonate. Expert Rev Respir Med. 2023;17(2):155–170. doi:10.1080/17476348.2023.2183843
   PubMed Web of Science ®Google Scholar
• Lam R, Schilling D, Scottoline B, et al. The effect of extended continuous positive airway pressure on changes in lung volumes in stable premature infants: a randomized controlled trial. J Pediatr. 2020;217:66–72.e1. doi:10.1016/j.jpeds.2019.07.074
   PubMed Web of Science ®Google Scholar
• Stewart A, Brion LP, Ambrosio-Perez I. Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev. 2011;9:CD001817. doi:10.1002/14651858.CD001817.pub2
   Google Scholar
• Hou S, Yu Y, Wu Y, et al. Association between antibiotic overexposure and adverse outcomes in very-low-birth-weight infants without culture-proven sepsis or necrotizing enterocolitis: a multicenter prospective study. Indian J Pediatr. 2022;89(8):785–792. doi:10.1007/s12098-021-04023-w
   PubMed Web of Science ®Google Scholar
• Hansmann G, Koestenberger M, Alastalo TP, et al. 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: the European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT. J Heart Lung Transplant. 2019;38(9):879–901. doi:10.1016/j.healun.2019.06.022
   PubMed Web of Science ®Google Scholar
• Duijts L, van Meel ER, Moschino L, et al. European respiratory society guideline on long-term management of children with bronchopulmonary dysplasia. Eur Respir J. 2020;55(1):1900788. doi:10.1183/13993003.00788-2019
   PubMed Web of Science ®Google Scholar
• Bhandari A, Schramm CM, Kimble C, Pappagallo M, Hussain N. Effect of a short course of prednisolone in infants with oxygen-dependent bronchopulmonary dysplasia. Pediatrics. 2008;121(2):e344–9. doi:10.1542/peds.2006-3668
   PubMed Web of Science ®Google Scholar
• Miller AN, Moise AA, Cottrell L, Loomis K, Polak M, Gest A. Linear growth is associated with successful respiratory support weaning in infants with bronchopulmonary dysplasia. J Perinatol. 2022;42(4):544–545. doi:10.1038/s41372-022-01322-8
   PubMed Web of Science ®Google Scholar
• Miller AN, Curtiss J, Taylor SN, Backes CH, Kielt MJ. A review and guide to nutritional care of the infant with established bronchopulmonary dysplasia. J Perinatol. 2023;43(3):402–410. doi:10.1038/s41372-022-01578-0
   PubMed Web of Science ®Google Scholar
• Narayan O, Bentley A, Mowbray K, et al. Updated cost-effectiveness analysis of palivizumab (Synagis) for the prophylaxis of respiratory syncytial virus in infant populations in the UK. J Med Econ. 2020:1–13. doi:10.1080/13696998.2020.1836923
   PubMed Web of Science ®Google Scholar
• Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;3(3):CD004454. doi:10.1002/14651858.CD004454.pub3
   PubMed Web of Science ®Google Scholar
• Chawla S, Wyckoff MH, Rysavy MA, et al. Association of antenatal steroid exposure at 21 to 22 weeks of gestation with neonatal survival and survival without morbidities. JAMA Netw Open. 2022;5(9):e2233331. doi:10.1001/jamanetworkopen.2022.33331
   PubMed Web of Science ®Google Scholar
• Parikh S, Reichman B, Kusuda S, et al. Trends, characteristic, and outcomes of preterm infants who received postnatal corticosteroid: a cohort study from 7 high-income countries. Neonatology. 2023:1–10. doi:10.1159/000530128
   Web of Science ®Google Scholar
• Kemp MW, Jobe AH, Usuda H, et al. Efficacy and safety of antenatal steroids. Am J Physiol Regul Integr Comp Physiol. 2018;315(4):R825–R839. doi:10.1152/ajpregu.00193.2017
   PubMed Web of Science ®Google Scholar
• Daskalakis G, Pergialiotis V, Domellöf M, et al. European guidelines on perinatal care: corticosteroids for women at risk of preterm birth. J Matern Fetal Neonatal Med. 2023;36(1):2160628. doi:10.1080/14767058.2022.2160628
   PubMed Web of Science ®Google Scholar
• Dunn MS, Kaempf J, de Klerk A, et al. Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates. Pediatrics. 2011;128(5):e1069–76. doi:10.1542/peds.2010-3848
   PubMed Web of Science ®Google Scholar
• Morley CJ, Davis PG, Doyle LW, et al. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med. 2008;358(7):700–708. doi:10.1056/NEJMoa072788
   PubMed Web of Science ®Google Scholar
• Finer NN, Carlo WA, Walsh MC, et al. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med. 2010;362(21):1970–1979. doi:10.1056/NEJMoa0911783
   PubMed Web of Science ®Google Scholar
• Sandri F, Plavka R, Ancora G, et al. Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics. 2010;125(6):e1402–9. doi:10.1542/peds.2009-2131
   PubMed Web of Science ®Google Scholar
• Schmölzer GM, Kumar M, Pichler G, Aziz K, O’Reilly M, Cheung PY. Non-invasive versus invasive respiratory support in preterm infants at birth: systematic review and meta-analysis. BMJ. 2013;347(oct17 3):f5980. doi:10.1136/bmj.f5980
   PubMedGoogle Scholar
• Wright CJ, Glaser K, Speer CP, Härtel C, Roehr CC. Noninvasive ventilation and exogenous surfactant in times of ever decreasing gestational age: how do we make the most of these tools? J Pediatr. 2022;247:138–146. doi:10.1016/j.jpeds.2022.04.011
   PubMed Web of Science ®Google Scholar
• Dargaville PA, Gerber A, Johansson S, et al. Incidence and outcome of CPAP failure in preterm infants. Pediatrics. 2016;138(1). doi:10.1542/peds.2015-3985
   PubMed Web of Science ®Google Scholar
• Sweet DG, Carnielli VP, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome: 2022 update. Neonatology. 2023;120(1):3–23. doi:10.1159/000528914
   PubMed Web of Science ®Google Scholar
• Capasso L, Pacella D, Migliaro F, et al. Can lung ultrasound score accurately predict surfactant replacement? A systematic review and meta-analysis of diagnostic test studies. Pediatr Pulmonol. 2023;58(5):1427–1437. doi:10.1002/ppul.26337
   PubMed Web of Science ®Google Scholar
• Abdel-Latif ME, Davis PG, Wheeler KI, De Paoli AG, Dargaville PA. Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome. Cochrane Database Syst Rev. 2021;5(5):CD011672. doi:10.1002/14651858.CD011672.pub2
   PubMedGoogle Scholar
• Kesler H, Lohmeier K, Hoehn T, Kribs A, Peinemann F. Thin-catheter surfactant application for respiratory distress syndrome in spontaneously breathing preterm infants: a meta-analysis of randomized clinical trials. Curr Pediatr Rev. 2022;18(4):286–300. doi:10.2174/1573396318666220404194857
   PubMed Web of Science ®Google Scholar
• Dargaville PA, Kamlin COF, Orsini F, et al. Effect of minimally invasive surfactant therapy vs sham treatment on death or bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: the OPTIMIST-A randomized clinical trial. JAMA. 2021;326(24):2478–2487. doi:10.1001/jama.2021.21892
   PubMed Web of Science ®Google Scholar
• Härtel C, Herting E, Humberg A, et al. Association of administration of surfactant using less invasive methods with outcomes in extremely preterm infants less than 27 weeks of gestation. JAMA Netw Open. 2022;5(8):e2225810. doi:10.1001/jamanetworkopen.2022.25810
   PubMed Web of Science ®Google Scholar
• Herting E, Härtel C, Göpel W. Less invasive surfactant administration: best practices and unanswered questions. Curr Opin Pediatr. 2020;32(2):228–234. doi:10.1097/MOP.0000000000000878
   PubMed Web of Science ®Google Scholar
• Kakkilaya V, Gautham KS. Should less invasive surfactant administration (LISA) become routine practice in US neonatal units? Pediatr Res. 2023;93(5):1188–1198. doi:10.1038/s41390-022-02265-8
   PubMed Web of Science ®Google Scholar
• Oei JL, Finer NN, Saugstad OD, et al. Outcomes of oxygen saturation targeting during delivery room stabilisation of preterm infants. Arch Dis Child Fetal Neonatal Ed. 2018;103(5):F446–F454. doi:10.1136/archdischild-2016-312366
   PubMed Web of Science ®Google Scholar
• Söderström F, Ågren J, Sindelar R. Early extubation is associated with shorter duration of mechanical ventilation and lower incidence of bronchopulmonary dysplasia. Early Hum Dev. 2021;163:105467. doi:10.1016/j.earlhumdev.2021.105467
   PubMed Web of Science ®Google Scholar
• Berger J, Mehta P, Bucholz E, Dziura J, Bhandari V. Impact of early extubation and reintubation on the incidence of bronchopulmonary dysplasia in neonates. Am J Perinatol. 2014;31(12):1063–1072. doi:10.1055/s-0034-1371702
   PubMed Web of Science ®Google Scholar
• Shalish W, Keszler M, Kovacs L, et al. Age at first extubation attempt and death or respiratory morbidities in extremely preterm infants. J Pediatr. 2023;252:124–130.e3. doi:10.1016/j.jpeds.2022.08.025
   PubMed Web of Science ®Google Scholar
• Sammour I, Karnati S. Non-invasive respiratory support of the premature neonate: from physics to bench to practice. Front Pediatr. 2020;8:214. doi:10.3389/fped.2020.00214
   PubMed Web of Science ®Google Scholar
• Prakash R, De Paoli AG, Davis PG, Oddie SJ, McGuire W. Bubble devices versus other pressure sources for nasal continuous positive airway pressure in preterm infants. Cochrane Database Syst Rev. 2023;3(3):CD015130. doi:10.1002/14651858.CD015130
   PubMedGoogle Scholar
• Avila-Alvarez A, García-Muñoz Rodrigo F, Solís-García G, et al. Nasal intermittent positive pressure ventilation and bronchopulmonary dysplasia among very preterm infants never intubated during the first neonatal admission: a multicenter cohort study. Front Pediatr. 2022;10:896331. doi:10.3389/fped.2022.896331
   PubMed Web of Science ®Google Scholar
• Zhu X, Qi H, Feng Z, Shi Y, De Luca D, NOP-ENS G. Noninvasive high-frequency oscillatory ventilation vs nasal continuous positive airway pressure vs nasal intermittent positive pressure ventilation as postextubation support for preterm neonates in china: a randomized clinical trial. JAMA Pediatr. 2022;176(6):551–559. doi:10.1001/jamapediatrics.2022.0710
   PubMed Web of Science ®Google Scholar
• Zhu X, Li F, Shi Y, Feng Z, De Luca D; Group NOP-ENS. Effectiveness of nasal continuous positive airway pressure vs nasal intermittent positive pressure ventilation vs noninvasive high-frequency oscillatory ventilation as support after extubation of neonates born extremely preterm or with more severe respiratory failure: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2023;6(7):e2321644. doi:10.1001/jamanetworkopen.2023.21644
   PubMed Web of Science ®Google Scholar
• Latremouille S, Bhuller M, Shalish W, Sant’Anna G. Cardiorespiratory effects of NIV-NAVA, NIPPV, and NCPAP shortly after extubation in extremely preterm infants: a randomized crossover trial. Pediatr Pulmonol. 2021;56(10):3273–3282. doi:10.1002/ppul.25607
   PubMed Web of Science ®Google Scholar
• Goel D, Oei JL, Smyth J, Schindler T. Diaphragm-triggered non-invasive respiratory support in preterm infants. Cochrane Database Syst Rev. 2020;3:CD012935. doi:10.1002/14651858.CD012935.pub2
   PubMedGoogle Scholar
• Shin SH, Kim SH, Song IG, Jung YH, Kim EK, Kim HS. Noninvasive neurally adjusted ventilation in postextubation stabilization of preterm infants: a randomized controlled study. J Pediatr. 2022;247:53–59.e1. doi:10.1016/j.jpeds.2022.04.025
   PubMed Web of Science ®Google Scholar
• Makker K, Cortez J, Jha K, et al. Comparison of extubation success using noninvasive positive pressure ventilation (NIPPV) versus noninvasive neurally adjusted ventilatory assist (NI-NAVA). J Perinatol. 2020;40(8):1202–1210. doi:10.1038/s41372-019-0578-4
   PubMed Web of Science ®Google Scholar
• Dagle JM, Rysavy MA, Hunter SK, et al. Cardiorespiratory management of infants born at 22 weeks’ gestation: the Iowa approach. Semin Perinatol. 2022;46(1):151545. doi:10.1016/j.semperi.2021.151545
   PubMed Web of Science ®Google Scholar
• Keszler M, Sant’Anna G. Mechanical Ventilation and Bronchopulmonary Dysplasia. Clin Perinatol. 2015;42(4):781–796. doi:10.1016/j.clp.2015.08.006
   PubMed Web of Science ®Google Scholar
• Wallström L, Sjöberg A, Sindelar R. Early volume targeted ventilation in preterm infants born at 22–25 weeks of gestational age. Pediatr Pulmonol. 2021;56(5):1000–1007. doi:10.1002/ppul.25271
   PubMed Web of Science ®Google Scholar
• Ackermann BW, Klotz D, Hentschel R, Thome UH, van Kaam AH. High-frequency ventilation in preterm infants and neonates. Pediatr Res. 2023;93(7):1810–1818. doi:10.1038/s41390-021-01639-8
   PubMed Web of Science ®Google Scholar
• The HIFI Study Group. High-frequency oscillatory ventilation compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants. N Engl J Med. 1989;320(2):88–93. doi:10.1056/NEJM198901123200204
   PubMed Web of Science ®Google Scholar
• Zivanovic S, Peacock J, Alcazar-Paris M, et al. Late outcomes of a randomized trial of high-frequency oscillation in neonates. N Engl J Med. 2014;370(12):1121–1130. doi:10.1056/NEJMoa1309220
   PubMed Web of Science ®Google Scholar
• Harris C, Bisquera A, Lunt A, Peacock JL, Greenough A. Outcomes of the neonatal trial of high-frequency oscillation at 16 to 19 years. N Engl J Med. 2020;383(7):689–691. doi:10.1056/NEJMc2008677
   PubMed Web of Science ®Google Scholar
• Solís-García G, Ramos-Navarro C, González-Pacheco N, Sánchez-Luna M. Lung protection strategy with high-frequency oscillatory ventilation improves respiratory outcomes at two years in preterm respiratory distress syndrome: a before and after, quality improvement study. J Matern Fetal Neonatal Med. 2022;35(26):10698–10705. doi:10.1080/14767058.2022.2155040
   PubMed Web of Science ®Google Scholar
• Sindelar R, Nakanishi H, Stanford AH, Colaizy TT, Klein JM. Respiratory management for extremely premature infants born at 22 to 23 weeks of gestation in proactive centers in Sweden, Japan, and USA. Semin Perinatol. 2022;46(1):151540. doi:10.1016/j.semperi.2021.151540
   PubMed Web of Science ®Google Scholar
• Watkins PL, Dagle JM, Bell EF, Colaizy TT. Outcomes at 18 to 22 months of corrected age for infants born at 22 to 25 weeks of gestation in a center practicing active management. J Pediatr. 2020;217:52–58.e1. doi:10.1016/j.jpeds.2019.08.028
   PubMed Web of Science ®Google Scholar
• Laughon MM, Langer JC, Bose CL, et al. Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants. Am J Respir Crit Care Med. 2011;183(12):1715–1722. doi:10.1164/rccm.201101-0055OC
   PubMed Web of Science ®Google Scholar
• Fang SJ, Su CH, Liao DL, et al. Neurally adjusted ventilatory assist for rapid weaning in preterm infants. Pediatr Int. 2023;65(1):e15360. doi:10.1111/ped.15360
   PubMed Web of Science ®Google Scholar
• Schmidt B, Roberts RS, Davis P, et al. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med. 2007;357(19):1893–1902. doi:10.1056/NEJMoa073679
   PubMed Web of Science ®Google Scholar
• Patel RM, Leong T, Carlton DP, Vyas-Read S. Early caffeine therapy and clinical outcomes in extremely preterm infants. J Perinatol. 2013;33(2):134–140. doi:10.1038/jp.2012.52
   PubMed Web of Science ®Google Scholar
• Dobson NR, Patel RM, Smith PB, et al. Trends in caffeine use and association between clinical outcomes and timing of therapy in very low birth weight infants. J Pediatr. 2014;164(5):992–998.e3. doi:10.1016/j.jpeds.2013.12.025
   PubMed Web of Science ®Google Scholar
• Szatkowski L, Fateh S, Abramson J, et al. Observational cohort study of use of caffeine in preterm infants and association between early caffeine use and neonatal outcomes. Arch Dis Child Fetal Neonatal Ed. 2023;108(5):505–510. doi:10.1136/archdischild-2022-324919
   PubMed Web of Science ®Google Scholar
• Lodha A, Seshia M, McMillan DD, et al. Association of early caffeine administration and neonatal outcomes in very preterm neonates. JAMA Pediatr. 2015;169(1):33–38. doi:10.1001/jamapediatrics.2014.2223
   PubMed Web of Science ®Google Scholar
• Lodha A, Entz R, Synnes A, et al. Early Caffeine Administration and Neurodevelopmental Outcomes in Preterm Infants. Pediatrics. 2019;143(1). doi:10.1542/peds.2018-1348
   PubMed Web of Science ®Google Scholar
• Schmidt B, Roberts RS, Anderson PJ, et al. Academic performance, motor function, and behavior 11 years after neonatal caffeine citrate therapy for apnea of prematurity: an 11-year follow-up of the CAP randomized clinical trial. JAMA Pediatr. 2017;171(6):564–572. doi:10.1001/jamapediatrics.2017.0238
   PubMed Web of Science ®Google Scholar
• Doyle LW, Ranganathan S, Cheong JLY. Neonatal caffeine treatment and respiratory function at 11 years in children under 1251 g at birth. Am J Respir Crit Care Med. 2017;196(10):1318–1324. doi:10.1164/rccm.201704-0767OC
   PubMed Web of Science ®Google Scholar
• Ferguson KN, Roberts CT, Manley BJ, Davis PG. Interventions to Improve Rates of Successful Extubation in Preterm Infants: a Systematic Review and Meta-analysis. JAMA Pediatr. 2017;171(2):165–174. doi:10.1001/jamapediatrics.2016.3015
   PubMed Web of Science ®Google Scholar
• Kraaijenga JV, Hutten GJ, de Jongh FH, van Kaam AH. The effect of caffeine on diaphragmatic activity and tidal volume in preterm infants. J Pediatr. 2015;167(1):70–75. doi:10.1016/j.jpeds.2015.04.040
   PubMed Web of Science ®Google Scholar
• Chen S, Wu Q, Zhong D, Li C, Du L. Caffeine prevents hyperoxia-induced lung injury in neonatal mice through NLRP3 inflammasome and NF-κB pathway. Respir Res. 2020;21(1):140. doi:10.1186/s12931-020-01403-2
   PubMed Web of Science ®Google Scholar
• Zhao W, Ma L, Cai C, Gong X. Caffeine Inhibits NLRP3 inflammasome activation by suppressing MAPK/NF-κB and A2aR signaling in LPS-Induced THP-1 macrophages. Int J Biol Sci. 2019;15(8):1571–1581. doi:10.7150/ijbs.34211
   PubMed Web of Science ®Google Scholar
• Dumpa V, Nielsen L, Wang H, Kumar VHS. Caffeine is associated with improved alveolarization and angiogenesis in male mice following hyperoxia induced lung injury. BMC Pulm Med. 2019;19(1):138. doi:10.1186/s12890-019-0903-x
   PubMedGoogle Scholar
• Tian C, Li D, Fu J. Molecular mechanism of caffeine in preventing bronchopulmonary dysplasia in premature infants. Front Pediatr. 2022;10:902437. doi:10.3389/fped.2022.902437
   PubMed Web of Science ®Google Scholar
• Endesfelder S, Strauß E, Scheuer T, Schmitz T, Bührer C. Antioxidative effects of caffeine in a hyperoxia-based rat model of bronchopulmonary dysplasia. Respir Res. 2019;20(1):88. doi:10.1186/s12931-019-1063-5
   PubMedGoogle Scholar
• Yuan Y, Yang Y, Lei X, Dong W. Caffeine and bronchopulmonary dysplasia: clinical benefits and the mechanisms involved. Pediatr Pulmonol. 2022;57(6):1392–1400. doi:10.1002/ppul.25898
   PubMed Web of Science ®Google Scholar
• Moschino L, Zivanovic S, Hartley C, Trevisanuto D, Baraldi E, Roehr CC. Caffeine in preterm infants: where are we in 2020? ERJ Open Res. 2020;6(1):00330–2019. doi:10.1183/23120541.00330-2019
   PubMedGoogle Scholar
• Brattström P, Russo C, Ley D, Bruschettini M. High-versus low-dose caffeine in preterm infants: a systematic review and meta-analysis. Acta Paediatr. 2019;108(3):401–410. doi:10.1111/apa.14586
   PubMed Web of Science ®Google Scholar
• Chen J, Jin L, Chen X. Efficacy and safety of different maintenance doses of caffeine citrate for treatment of apnea in premature infants: a systematic review and meta-analysis. Biomed Res Int. 2018;2018:9061234. doi:10.1155/2018/9061234
   PubMed Web of Science ®Google Scholar
• Mohammed S, Nour I, Shabaan AE, Shouman B, Abdel-Hady H, Nasef N. High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial. Eur J Pediatr. 2015;174(7):949–956. doi:10.1007/s00431-015-2494-8
   PubMed Web of Science ®Google Scholar
• Puia-Dumitrescu M, Smith PB, Zhao J, et al. Dosing and safety of off-label use of caffeine citrate in premature infants. J Pediatr. 2019;211:27–32.e1. doi:10.1016/j.jpeds.2019.04.028
   PubMed Web of Science ®Google Scholar
• Long JY, Guo HL, He X, et al. Caffeine for the pharmacological treatment of apnea of prematurity in the NICU: dose selection conundrum, therapeutic drug monitoring and genetic factors. Front Pharmacol. 2021;12:681842. doi:10.3389/fphar.2021.681842
   PubMed Web of Science ®Google Scholar
• Ambalavanan N, Kennedy K, Tyson J, Carlo WA. Survey of vitamin A supplementation for extremely-low-birth-weight infants: is clinical practice consistent with the evidence? J Pediatr. 2004;145(3):304–307. doi:10.1016/j.jpeds.2004.04.046
   PubMed Web of Science ®Google Scholar
• Tolia VN, Murthy K, McKinley PS, Bennett MM, Clark RH. The effect of the national shortage of vitamin A on death or chronic lung disease in extremely low-birth-weight infants. JAMA Pediatr. 2014;168(11):1039–1044. doi:10.1001/jamapediatrics.2014.1353
   PubMed Web of Science ®Google Scholar
• Araki S, Kato S, Namba F, Ota E, Ehrhardt H. Vitamin A to prevent bronchopulmonary dysplasia in extremely low birth weight infants: a systematic review and meta-analysis. PLoS One. 2018;13(11):e0207730. doi:10.1371/journal.pone.0207730
   PubMed Web of Science ®Google Scholar
• Shaffer ML, Baud O, Lacaze-Masmonteil T, Peltoniemi OM, Bonsante F, Watterberg KL. Effect of prophylaxis for early adrenal insufficiency using low-dose hydrocortisone in very preterm infants: an individual patient data meta-analysis. J Pediatr. 2019;207:136–142.e5. doi:10.1016/j.jpeds.2018.10.004
   PubMed Web of Science ®Google Scholar
• Baud O, Maury L, Lebail F, et al. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial. Lancet. 2016;387(10030):1827–1836. doi:10.1016/S0140-6736(16)00202-6
   PubMed Web of Science ®Google Scholar
• Renolleau C, Toumazi A, Bourmaud A, et al. Association between Baseline cortisol serum concentrations and the effect of prophylactic hydrocortisone in extremely preterm infants. J Pediatr. 2021;234:65–70.e3. doi:10.1016/j.jpeds.2020.12.057
   PubMed Web of Science ®Google Scholar
• Watterberg KL, Scott SM. Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia. Pediatrics. 1995;95(1):120–125. doi:10.1542/peds.95.1.120
   PubMed Web of Science ®Google Scholar
• El-Khuffash A, James AT, Corcoran JD, et al. A patent ductus arteriosus severity score predicts chronic lung disease or death before discharge. J Pediatr. 2015;167(6):1354–1361.e2. doi:10.1016/j.jpeds.2015.09.028
   PubMed Web of Science ®Google Scholar
• Clyman RI, Hills NK, Liebowitz M, Johng S. Relationship between duration of infant exposure to a moderate-to-large patent ductus arteriosus shunt and the risk of developing bronchopulmonary dysplasia or death before 36 weeks. Am J Perinatol. 2020;37(2):216–223. doi:10.1055/s-0039-1697672
   PubMed Web of Science ®Google Scholar
• Gentle SJ, Travers CP, Clark M, Carlo WA, Ambalavanan N. Patent ductus arteriosus and development of bronchopulmonary dysplasia with pulmonary hypertension. Am J Respir Crit Care Med. 2022. doi:10.1164/rccm.202203-0570OC
   Google Scholar
• Relangi D, Somashekar S, Jain D, et al. Changes in patent ductus arteriosus treatment strategy and respiratory outcomes in premature infants. J Pediatr. 2021;235:58–62. doi:10.1016/j.jpeds.2021.04.030
   PubMed Web of Science ®Google Scholar
• Clyman RI, Hills NK. Patent ductus arteriosus (PDA) and pulmonary morbidity: can early targeted pharmacologic PDA treatment decrease the risk of bronchopulmonary dysplasia? Semin Perinatol. 2023;47(2):151718. doi:10.1016/j.semperi.2023.151718
   PubMed Web of Science ®Google Scholar
• El-Khuffash A, Bussmann N, Breatnach CR, et al. A pilot randomized controlled trial of early targeted patent ductus arteriosus treatment using a risk based severity score (The PDA RCT). J Pediatr. 2021;229:127–133. doi:10.1016/j.jpeds.2020.10.024
   PubMed Web of Science ®Google Scholar
• Hundscheid T, Onland W, Kooi EMW, et al. Expectant management or early ibuprofen for patent ductus arteriosus. N Engl J Med. 2023;388(11):980–990. doi:10.1056/NEJMoa2207418
   PubMed Web of Science ®Google Scholar
• Clyman RI, Kaempf J, Liebowitz M, et al. Prolonged tracheal intubation and the association between patent ductus arteriosus and bronchopulmonary dysplasia: a secondary analysis of the PDA-TOLERATE trial. J Pediatr. 2021;229:283–288.e2. doi:10.1016/j.jpeds.2020.09.047
   PubMed Web of Science ®Google Scholar
• Giesinger RE, Rios DR, Chatmethakul T, et al. Impact of early hemodynamic screening on extremely preterm outcomes in a high-performance center. Am J Respir Crit Care Med. 2023;208(3):290–300. doi:10.1164/rccm.202212-2291OC
   PubMed Web of Science ®Google Scholar
• El-Khuffash A, Rios DR, McNamara PJ. Toward a rational approach to patent ductus arteriosus trials: selecting the population of interest. J Pediatr. 2021;233:11–13. doi:10.1016/j.jpeds.2021.01.012
   PubMed Web of Science ®Google Scholar
• Shelton EL, Singh GK, Nichols CG. Novel drug targets for ductus arteriosus manipulation: looking beyond prostaglandins. Semin Perinatol. 2018;42(4):221–227. doi:10.1053/j.semperi.2018.05.004
   PubMed Web of Science ®Google Scholar
• Makoni M, Chatmethakul T, Giesinger R, McNamara PJ. Hemodynamic precision in the neonatal intensive care unit using targeted neonatal echocardiography. J Vis Exp. 2023;191. doi:10.3791/64257
   PubMedGoogle Scholar
• Backes CH, Hill KD, Shelton EL, et al. Patent ductus arteriosus: a contemporary perspective for the pediatric and adult cardiac care provider. J Am Heart Assoc. 2022;11(17):e025784. doi:10.1161/JAHA.122.025784
   PubMed Web of Science ®Google Scholar
• Chu A, de St Maurice A, Sim MS, Kallapur SG. Neonatal mycoplasma and ureaplasma infections. Pediatr Ann. 2020;49(7):e305–e312. doi:10.3928/19382359-20200625-01
   PubMed Web of Science ®Google Scholar
• Yoder BA, Coalson JJ, Winter VT, Siler-Khodr T, Duffy LB, Cassell GH. Effects of antenatal colonization with ureaplasma urealyticum on pulmonary disease in the immature baboon. Pediatr Res. 2003;54(6):797–807. doi:10.1203/01.PDR.0000091284.84322.16
   PubMed Web of Science ®Google Scholar
• Nunes CR, Procianoy RS, Corso AL, Silveira RC. Use of azithromycin for the prevention of lung injury in mechanically ventilated preterm neonates: a randomized controlled trial. Neonatology. 2020;117(4):522–528. doi:10.1159/000509462
   PubMed Web of Science ®Google Scholar
• Viscardi RM, Terrin ML, Magder LS, et al. Randomised trial of azithromycin to eradicate. Arch Dis Child Fetal Neonatal Ed. 2020;105(6):615–622. doi:10.1136/archdischild-2019-318122
   PubMed Web of Science ®Google Scholar
• Ballard HO, Shook LA, Bernard P, et al. Use of azithromycin for the prevention of bronchopulmonary dysplasia in preterm infants: a randomized, double-blind, placebo controlled trial. Pediatr Pulmonol. 2011;46(2):111–118. doi:10.1002/ppul.21352
   PubMed Web of Science ®Google Scholar
• Lal CV, Travers C, Aghai ZH, et al. The airway microbiome at birth. Sci Rep. 2016;6(1):31023. doi:10.1038/srep31023
   PubMed Web of Science ®Google Scholar
• Freeman AE, Willis KA, Qiao L, et al. Microbial-induced redox imbalance in the neonatal lung is ameliorated by live biotherapeutics. Am J Respir Cell Mol Biol. 2023;68(3):267–278. doi:10.1165/rcmb.2021-0508OC
   PubMed Web of Science ®Google Scholar
• Willis KA, Siefker DT, Aziz MM, et al. Perinatal maternal antibiotic exposure augments lung injury in offspring in experimental bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2020;318(2):L407–L418. doi:10.1152/ajplung.00561.2018
   PubMed Web of Science ®Google Scholar
• Chen WY, Lo YC, Huang PH, et al. Increased antibiotic exposure in early life is associated with adverse outcomes in very low birth weight infants. J Chin Med Assoc. 2022;85(9):939–943. doi:10.1097/JCMA.0000000000000749
   PubMed Web of Science ®Google Scholar
• Yu W, Zhang L, Li S, et al. Early antibiotic use and neonatal outcomes among preterm infants without infections. Pediatrics. 2023;151(5). doi:10.1542/peds.2022-059427
   Web of Science ®Google Scholar
• Chen X, Huang X, Lin Y, Lin B, Yang C, Huang Z. Association of Ureaplasma infection pattern and azithromycin treatment effect with bronchopulmonary dysplasia in Ureaplasma positive infants: a cohort study. BMC Pulm Med. 2023;23(1):229. doi:10.1186/s12890-023-02522-4
   PubMed Web of Science ®Google Scholar
• Sharma R, Bhandari V. Fluid balance in early postnatal life: should we keep the babies dry to prevent bronchopulmonary dysplasia? Pediatr Res. 2021;90(2):240–241. doi:10.1038/s41390-021-01589-1
   PubMed Web of Science ®Google Scholar
• Thiess T, Lauer T, Woesler A, et al. Correlation of early nutritional supply and development of bronchopulmonary dysplasia in preterm infants <1000 g. Front Pediatr. 2021;9:741365. doi:10.3389/fped.2021.741365
   PubMed Web of Science ®Google Scholar
• Stefanescu BM, Gillam-Krakauer M, Stefanescu AR, Markham M, Kosinski JL. Very low birth weight infant care: adherence to a new nutrition protocol improves growth outcomes and reduces infectious risk. Early Hum Dev. 2016;94:25–30. doi:10.1016/j.earlhumdev.2016.01.011
   PubMed Web of Science ®Google Scholar
• Miller M, Donda K, Bhutada A, Rastogi D, Rastogi S. Transitioning preterm infants from parenteral nutrition: a comparison of 2 protocols. JPEN J Parenter Enteral Nutr. 2017;41(8):1371–1379. doi:10.1177/0148607116664560
   PubMed Web of Science ®Google Scholar
• Behnke J, Estreich V, Oehmke F, Zimmer KP, Windhorst A, Ehrhardt H. Compatibility of rapid enteral feeding advances and noninvasive ventilation in preterm infants-An observational study. Pediatr Pulmonol. 2022;57(5):1117–1126. doi:10.1002/ppul.25868
   PubMed Web of Science ®Google Scholar
• Patel AL, Johnson TJ, Robin B, et al. Influence of own mother’s milk on bronchopulmonary dysplasia and costs. Arch Dis Child Fetal Neonatal Ed. 2017;102(3):F256–F261. doi:10.1136/archdischild-2016-310898
   PubMed Web of Science ®Google Scholar
• Patel AL, Johnson TJ, Meier PP. Racial and socioeconomic disparities in breast milk feedings in US neonatal intensive care units. Pediatr Res. 2021;89(2):344–352. doi:10.1038/s41390-020-01263-y
   PubMed Web of Science ®Google Scholar
• Jensen EA, DeMauro SB, Kornhauser M, Aghai ZH, Greenspan JS, Dysart KC. Effects of multiple ventilation courses and duration of mechanical ventilation on respiratory outcomes in extremely low-birth-weight infants. JAMA Pediatr. 2015;169(11):1011–1017. doi:10.1001/jamapediatrics.2015.2401
   PubMed Web of Science ®Google Scholar
• Rysavy MA, Mehler K, Oberthür A, et al. An immature science: intensive care for infants born at ≤23 weeks of gestation. J Pediatr. 2021;233(233):16–25.e1. doi:10.1016/j.jpeds.2021.03.006
   PubMedGoogle Scholar
• Doyle LW, Halliday HL, Ehrenkranz RA, Davis PG, Sinclair JC. Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk for chronic lung disease. Pediatrics. 2005;115(3):655–661. doi:10.1542/peds.2004-1238
   PubMed Web of Science ®Google Scholar
• Harmon HM, Jensen EA, Tan S, et al. Timing of postnatal steroids for bronchopulmonary dysplasia: association with pulmonary and neurodevelopmental outcomes. J Perinatol. 2020;40(4):616–627. doi:10.1038/s41372-020-0594-4
   PubMed Web of Science ®Google Scholar
• Cuna A, Lagatta JM, Savani RC, et al. Association of time of first corticosteroid treatment with bronchopulmonary dysplasia in preterm infants. Pediatr Pulmonol. 2021;56(10):3283–3292. doi:10.1002/ppul.25610
   PubMed Web of Science ®Google Scholar
• Baud O, Trousson C, Biran V, et al. Association between early low-dose hydrocortisone therapy in extremely preterm neonates and neurodevelopmental outcomes at 2 years of age. JAMA. 2017;317(13):1329–1337. doi:10.1001/jama.2017.2692
   PubMed Web of Science ®Google Scholar
• Halbmeijer NM, Onland W, Cools F, et al. Effect of systemic hydrocortisone in ventilated preterm infants on parent-reported behavioural outcomes at 2 years’ corrected age: follow-up of a randomised clinical trial. Arch Dis Child Fetal Neonatal Ed. 2023;108(4):373–379. doi:10.1136/archdischild-2022-324179
   PubMed Web of Science ®Google Scholar
• Onland W, Cools F, Kroon A, et al. Effect of hydrocortisone therapy initiated 7 to 14 days after birth on mortality or bronchopulmonary dysplasia among very preterm infants receiving mechanical ventilation: a randomized clinical trial. JAMA. 2019;321(4):354–363. doi:10.1001/jama.2018.21443
   PubMed Web of Science ®Google Scholar
• Watterberg KL, Walsh MC, Li L, et al. Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia. N Engl J Med. 2022;386(12):1121–1131. doi:10.1056/NEJMoa2114897
   PubMed Web of Science ®Google Scholar
• Gentle SJ, Rysavy MA, Li L, et al. Heterogeneity of treatment effects of hydrocortisone by risk of bronchopulmonary dysplasia or death among extremely preterm infants in the national institute of child health and human development neonatal research network trial: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2023;6(5):e2315315. doi:10.1001/jamanetworkopen.2023.15315
   PubMedGoogle Scholar
• Greenberg RG, Gayam S, Savage D, et al. Furosemide exposure and prevention of bronchopulmonary dysplasia in premature infants. J Pediatr. 2019;208:134–140.e2. doi:10.1016/j.jpeds.2018.11.043
   PubMed Web of Science ®Google Scholar
• Segar JL. Rethinking furosemide use for infants with bronchopulmonary dysplasia. Pediatr Pulmonol. 2020;55(5):1100–1103. doi:10.1002/ppul.24722
   PubMed Web of Science ®Google Scholar
• Thakur A, Fursule A. Lung ultrasound in neonates - An underused tool. J Med Imaging Radiat Oncol. 2022. doi:10.1111/1754-9485.13485
   PubMed Web of Science ®Google Scholar
• Abdel-Hady H, Shouman B, Aly H. Early weaning from CPAP to high flow nasal cannula in preterm infants is associated with prolonged oxygen requirement: a randomized controlled trial. Early Hum Dev. 2011;87(3):205–208. doi:10.1016/j.earlhumdev.2010.12.010
   PubMed Web of Science ®Google Scholar
• Taha DK, Kornhauser M, Greenspan JS, Dysart KC, Aghai ZH. High flow nasal cannula use is associated with increased morbidity and length of hospitalization in extremely low birth weight infants. J Pediatr. 2016;173:50–55.e1. doi:10.1016/j.jpeds.2016.02.051
   PubMed Web of Science ®Google Scholar
• van Delft B, Van Ginderdeuren F, Lefevere J, van Delft C, Cools F. Weaning strategies for the withdrawal of non-invasive respiratory support applying continuous positive airway pressure in preterm infants: a systematic review and meta-analysis. BMJ Paediatr Open. 2020;4(1):e000858. doi:10.1136/bmjpo-2020-000858
   PubMedGoogle Scholar
• Zhang EY, Bartman CM, Prakash YS, Pabelick CM, Vogel ER. Oxygen and mechanical stretch in the developing lung: risk factors for neonatal and pediatric lung disease. Front Med. 2023;10:1214108. doi:10.3389/fmed.2023.1214108
   Web of Science ®Google Scholar
• Kish MZ. Improving preterm infant outcomes: implementing an evidence-based oral feeding advancement protocol in the neonatal intensive care unit. Adv Neonatal Care. 2014;14(5):346–353. doi:10.1097/ANC.0000000000000099
   PubMed Web of Science ®Google Scholar
• McEvoy CT, Schilling D, Clay N, et al. Vitamin C supplementation for pregnant smoking women and pulmonary function in their newborn infants: a randomized clinical trial. JAMA. 2014;311(20):2074–2082. doi:10.1001/jama.2014.5217
   PubMed Web of Science ®Google Scholar
• McEvoy CT, Shorey-Kendrick LE, Milner K, et al. Vitamin C to pregnant smokers persistently improves infant airway function to 12 Months of age: a randomised trial. Eur Respir J. 2020;56(6):1902208. doi:10.1183/13993003.02208-2019
   Web of Science ®Google Scholar
• Shorey-Kendrick LE, McEvoy CT, O’Sullivan SM, et al. Impact of vitamin C supplementation on placental DNA methylation changes related to maternal smoking: association with gene expression and respiratory outcomes. Clin Epigenetics. 2021;13(1):177. doi:10.1186/s13148-021-01161-y
   PubMed Web of Science ®Google Scholar
• Buhimschi CS, Bahtiyar MO, Zhao G, et al. Antenatal N-acetylcysteine to improve outcomes of premature infants with intra-amniotic infection and inflammation (triple I): randomized clinical trial. Pediatr Res. 2021;89(1): 175–184. doi:10.1038/s41390-020-01106-w
   PubMed Web of Science ®Google Scholar
• McEvoy CT, Ballard PL, Ward RM, et al. Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE). Pediatr Res. 2020;88(4):629–636. doi:10.1038/s41390-020-0792-y
   PubMed Web of Science ®Google Scholar
• Hillman NH, Kemp MW, Fee E, et al. Budesonide with surfactant decreases systemic responses in mechanically ventilated preterm lambs exposed to fetal intra-amniotic lipopolysaccharide. Pediatr Res. 2021;90(2):328–334. doi:10.1038/s41390-020-01267-8
   PubMed Web of Science ®Google Scholar
• Hillman NH, Kothe TB, Schmidt AF, et al. Surfactant plus budesonide decreases lung and systemic responses to injurious ventilation in preterm sheep. Am J Physiol Lung Cell Mol Physiol. 2020;318(1):L41–L48. doi:10.1152/ajplung.00203.2019
   PubMed Web of Science ®Google Scholar
• Kothe TB, Royse E, Kemp MW, et al. Effects of budesonide and surfactant in preterm fetal sheep. Am J Physiol Lung Cell Mol Physiol. 2018;315(2):L193–L201. doi:10.1152/ajplung.00528.2017
   PubMed Web of Science ®Google Scholar
• Ley D, Hallberg B, Hansen-Pupp I, et al. rhIGF-1/rhIGFBP-3 in preterm infants: a phase 2 randomized controlled trial. J Pediatr. 2019;206:56–65.e8. doi:10.1016/j.jpeds.2018.10.033
   PubMed Web of Science ®Google Scholar
• Seedorf G, Kim C, Wallace B, et al. rhIGF-1/BP3 preserves lung growth and prevents pulmonary hypertension in experimental bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2020;201(9):1120–1134. doi:10.1164/rccm.201910-1975OC
   PubMed Web of Science ®Google Scholar
• Ahn SY, Chang YS, Lee MH, et al. Stem cells for bronchopulmonary dysplasia in preterm infants: a randomized controlled phase II trial. Stem Cells Transl Med. 2021;10(8):1129–1137. doi:10.1002/sctm.20-0330
   PubMed Web of Science ®Google Scholar
• Omar SA, Abdul-Hafez A, Ibrahim S, et al. Stem-cell therapy for bronchopulmonary dysplasia (BPD) in newborns. Cells. 2022;11(8):1275. doi:10.3390/cells11081275
   PubMed Web of Science ®Google Scholar
• Wu S, Benny M, Duara J, et al. Extracellular vesicles: pathogenic messengers and potential therapy for neonatal lung diseases. Front Pediatr. 2023;11:1205882. doi:10.3389/fped.2023.1205882
   PubMed Web of Science ®Google Scholar
• Abman SH, Collaco JM, Shepherd EG, et al. Interdisciplinary care of children with severe bronchopulmonary dysplasia. J Pediatr. 2017;181:12–28.e1. doi:10.1016/j.jpeds.2016.10.082
   PubMed Web of Science ®Google Scholar
• Shepherd EG, Knupp AM, Welty SE, Susey KM, Gardner WP, Gest AL. An interdisciplinary bronchopulmonary dysplasia program is associated with improved neurodevelopmental outcomes and fewer rehospitalizations. J Perinatol. 2012;32(1):33–38. doi:10.1038/jp.2011.45
   PubMed Web of Science ®Google Scholar
• Yung D, Jackson EO, Blumenfeld A, et al. A multidisciplinary approach to severe bronchopulmonary dysplasia is associated with resolution of pulmonary hypertension. Front Pediatr. 2023;11:1077422. doi:10.3389/fped.2023.1077422
   PubMed Web of Science ®Google Scholar
• Hansen TP, Noel-MacDonnell J, Kuckelman S, Norberg M, Truog W, Manimtim W. A multidisciplinary chronic lung disease team in a neonatal intensive care unit is associated with increased survival to discharge of infants with tracheostomy. J Perinatol. 2021;41(8):1963–1971. doi:10.1038/s41372-021-00974-2
   PubMed Web of Science ®Google Scholar
• Gibbs K, Jensen EA, Alexiou S, Munson D, Zhang H. Ventilation strategies in severe bronchopulmonary dysplasia. Neoreviews. 2020;21(4):e226–e237. doi:10.1542/neo.21-4-e226
   PubMedGoogle Scholar
• Akangire G, Manimtim W. Tracheostomy in infants with severe bronchopulmonary dysplasia: a review. Front Pediatr. 2022;10:1066367. doi:10.3389/fped.2022.1066367
   PubMed Web of Science ®Google Scholar
• Sindelar R, Shepherd EG, Ågren J, et al. Established severe BPD: is there a way out? Change of ventilatory paradigms. Pediatr Res. 2021;90(6):1139–1146. doi:10.1038/s41390-021-01558-8
   PubMed Web of Science ®Google Scholar
• Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol. 1998;29(7):710–717. doi:10.1016/S0046-8177(98)90280-5
   PubMed Web of Science ®Google Scholar
• Coalson JJ. Pathology of bronchopulmonary dysplasia. Semin Perinatol. 2006;30(4):179–184. doi:10.1053/j.semperi.2006.05.004
   PubMed Web of Science ®Google Scholar
• Özkan H, Duman N, Tüzün F. Pathophysiologically based ventilatory management of severe bronchopulmonary dysplasia. Turk Arch Pediatr. 2022;57(4):385–390. doi:10.5152/TurkArchPediatr.2022.22112
   PubMedGoogle Scholar
• Hysinger EB, Ahlfeld SK. Respiratory support strategies in the prevention and treatment of bronchopulmonary dysplasia. Front Pediatr. 2023;11:1087857. doi:10.3389/fped.2023.1087857
   PubMed Web of Science ®Google Scholar
• Shetty S, Hickey A, Rafferty GF, Peacock JL, Greenough A. Work of breathing during CPAP and heated humidified high-flow nasal cannula. Arch Dis Child Fetal Neonatal Ed. 2016;101(5):F404–7. doi:10.1136/archdischild-2015-309310
   PubMed Web of Science ®Google Scholar
• McKinney RL, Keszler M, Truog WE, et al. Multicenter experience with neurally adjusted ventilatory assist in infants with severe bronchopulmonary dysplasia. Am J Perinatol. 2021;38(S 01):e162–e166. doi:10.1055/s-0040-1708559
   PubMedGoogle Scholar
• Yallapragada S, Savani RC, Mūnoz-Blanco S, et al. Qualitative indications for tracheostomy and chronic mechanical ventilation in patients with severe bronchopulmonary dysplasia. J Perinatol. 2021;41(11):2651–2657. doi:10.1038/s41372-021-01165-9
   PubMed Web of Science ®Google Scholar
• DeMauro SB, D’Agostino JA, Bann C, et al. Developmental outcomes of very preterm infants with tracheostomies. J Pediatr. 2014;164(6):1303–10.e2. doi:10.1016/j.jpeds.2013.12.014
   PubMed Web of Science ®Google Scholar
• Levit OL, Shabanova V, Bazzy-Asaad A, Bizzarro MJ, Bhandari V. Risk factors for tracheostomy requirement in extremely low birth weight infants. J Matern Fetal Neonatal Med. 2018;31(4):447–452. doi:10.1080/14767058.2017.1287895
   PubMed Web of Science ®Google Scholar
• DeMauro SB, Wei JL, Lin RJ. Perspectives on neonatal and infant tracheostomy. Semin Fetal Neonatal Med. 2016;21(4):285–291. doi:10.1016/j.siny.2016.03.006
   PubMed Web of Science ®Google Scholar
• Hayes D, Wilson KC, Krivchenia K, et al. Home oxygen therapy for children. An official American thoracic society clinical practice guideline. Am J Respir Crit Care Med. 2019;199(3):e5–e23. doi:10.1164/rccm.201812-2276ST
   PubMed Web of Science ®Google Scholar
• Stenson BJ, Tarnow-Mordi WO, Darlow BA, et al. Oxygen saturation and outcomes in preterm infants. N Engl J Med. 2013;368(22):2094–2104. doi:10.1056/NEJMoa1302298
   PubMed Web of Science ®Google Scholar
• Slaughter JL, Stenger MR, Reagan PB. Variation in the use of diuretic therapy for infants with bronchopulmonary dysplasia. Pediatrics. 2013;131(4):716–723. doi:10.1542/peds.2012-1835
   PubMed Web of Science ®Google Scholar
• Slaughter JL, Stenger MR, Reagan PB, Jadcherla SR, Choonara I. Utilization of inhaled corticosteroids for infants with bronchopulmonary dysplasia. PLoS One. 2014;9(9):e106838. doi:10.1371/journal.pone.0106838
   PubMed Web of Science ®Google Scholar
• Sakaria RP, Dhanireddy R. Pharmacotherapy in Bronchopulmonary Dysplasia: what Is the Evidence? Front Pediatr. 2022;10:820259. doi:10.3389/fped.2022.820259
   PubMed Web of Science ®Google Scholar
• Nelin LD, Kielt MJ, Jebbia M, Jadcherla S, Shepherd EG. Bronchodilator responsiveness and dysanapsis in bronchopulmonary dysplasia. ERJ Open Res. 2022;8(3):00682–2021. doi:10.1183/23120541.00682-2021
   PubMedGoogle Scholar
• Cousins M, Hart K, Williams EM, Kotecha S. Impaired exercise outcomes with significant bronchodilator responsiveness in children with prematurity-associated obstructive lung disease. Pediatr Pulmonol. 2022;57(9):2161–2171. doi:10.1002/ppul.26019
   PubMed Web of Science ®Google Scholar
• Baraldi E, Bonetto G, Zacchello F, Filippone M. Low exhaled nitric oxide in school-age children with bronchopulmonary dysplasia and airflow limitation. Am J Respir Crit Care Med. 2005;171(1):68–72. doi:10.1164/rccm.200403-298OC
   PubMed Web of Science ®Google Scholar
• Bhandari A, Panitch H. An update on the post-NICU discharge management of bronchopulmonary dysplasia. Semin Perinatol. 2018;42(7):471–477. doi:10.1053/j.semperi.2018.09.011
   PubMed Web of Science ®Google Scholar
• Rastogi A, Luayon M, Ajayi OA, Pildes RS. Nebulized furosemide in infants with bronchopulmonary dysplasia. J Pediatr. 1994;125(6 Pt 1):976–979. doi:10.1016/s0022-3476(05)82018-9
   PubMed Web of Science ®Google Scholar
• Billion E, Hadchouel A, Garcelon N, Delacourt C, Drummond D. Intravenous pulses of methylprednisolone for infants with severe bronchopulmonary dysplasia and respiratory support after 3 months of age. Pediatr Pulmonol. 2021;56(1):74–82. doi:10.1002/ppul.25109
   PubMed Web of Science ®Google Scholar
• Sahebjami H, Domino M. Effects of postnatal dexamethasone treatment on development of alveoli in adult rats. Exp Lung Res. 1989;15(6):961–973. doi:10.3109/01902148909069638
   PubMed Web of Science ®Google Scholar
• Hwang JK, Shin SH, Kim EK, Kim SH, Kim HS. Association of newer definitions of bronchopulmonary dysplasia with pulmonary hypertension and long-term outcomes. Front Pediatr. 2023;11:1108925. doi:10.3389/fped.2023.1108925
   PubMed Web of Science ®Google Scholar
• Branescu I, Shetty S, Richards J, Vladareanu S, Kulkarni A. Pulmonary hypertension in preterm infants with moderate-to-severe bronchopulmonary dysplasia (BPD). Acta Paediatr. 2023;112(9):1877–1883. doi:10.1111/apa.16863
   PubMedGoogle Scholar
• Khemani E, McElhinney DB, Rhein L, et al. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics. 2007;120(6):1260–1269. doi:10.1542/peds.2007-0971
   PubMed Web of Science ®Google Scholar
• Berkelhamer SK, Mestan KK, Steinhorn RH. Pulmonary hypertension in bronchopulmonary dysplasia. Semin Perinatol. 2013;37(2):124–131. doi:10.1053/j.semperi.2013.01.009
   PubMed Web of Science ®Google Scholar
• Abman SH, Hansmann G, Archer SL, et al. Pediatric pulmonary hypertension: guidelines from the American heart association and American thoracic society. Circulation. 2015;132(21):2037–2099. doi:10.1161/CIR.0000000000000329
   PubMed Web of Science ®Google Scholar
• Chan S, Brugha R, Quyam S, Moledina S. Diagnosis and management of pulmonary hypertension in infants with bronchopulmonary dysplasia: a guide for paediatric respiratory specialists. Breathe. 2022;18(4):220209. doi:10.1183/20734735.0209-2022
   Web of Science ®Google Scholar
• Kehinde F, Marinescu A, Turchi R. Catch it before it breaks!: managing metabolic bone disease of prematurity. Curr Opin Pediatr. 2021;33(6):676–683. doi:10.1097/MOP.0000000000001060
   PubMed Web of Science ®Google Scholar
• Dani A, Hayes D, Guzman-Gomez A, et al. Lung transplantation for bronchopulmonary dysplasia. Chest. 2023;163(5):1166–1175. doi:10.1016/j.chest.2022.12.032
   PubMed Web of Science ®Google Scholar